Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002053 · ClinicalTrials.gov registry record · NA
A Double-Blind Placebo-Controlled Group Comparative Study To Evaluate the Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in Patients With AIDS Post First Episode PCP
A NA study, sponsored by Fisons.
- Completed
- Registry status
- NA
- Development phase
NCT00002053 is a NA study that has completed, run by Fisons.
The verdict
NCT00002053, a NA study, has completed, sponsored by Fisons.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To evaluate and compare the safety, tolerability, and efficacy of biweekly administration of aerosol pentamidine versus placebo when used as a prophylactic agent in patients who have recovered from their first episode of AIDS-associated Pneumocystis carinii pneumonia (PCP).
Interventions
- DRUG Pentamidine isethionate
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002053
The ClinicalTrials.gov registry entry for NCT00002053 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Fisons, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pentamidine isethionate is the first listed.
NCT00002053 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002053 about?
NCT00002053 is a clinical study titled "A Double-Blind Placebo-Controlled Group Comparative Study To Evaluate the Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in Patients With AIDS Post First Episode PCP". To evaluate and compare the safety, tolerability, and efficacy of biweekly administration of aerosol pentamidine versus placebo when used as a prophylactic agent in patients who have recovered from their first episode of AIDS-associated Pneumocystis carinii pneumonia (PCP).
What is the current status of trial NCT00002053?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002053?
The interventions under investigation include: Pentamidine isethionate (DRUG).
Who is sponsoring clinical trial NCT00002053?
This trial is sponsored by Fisons, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.